UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glutamatergic transmission in drug reward: implications for drug addiction

Frontiers in neuroscience, 2015-11, Vol.9, p.404-404

D'Souza, Manoranjan S

2015

Volltextzugriff (PDF)

Differential methamphetamine-induced behavioral effects in male and female mice lacking regulator of G Protein signaling 4

Behavioural brain research, 2022-04, Vol.423, p.113770-113770, Article 113770

2022

Volltextzugriff (PDF)

Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits

Frontiers in psychiatry, 2019-07, Vol.10, p.509-509

D'Souza, Manoranjan S

2019

Volltextzugriff (PDF)

Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype‑2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence

Journal of medicinal chemistry, 2014-05, Vol.57 (10), p.4154-4172

2014

Volltextzugriff (PDF)

Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence

Journal of medicinal chemistry, 2012-11, Vol.55 (22), p.9434-9445

2012

Volltextzugriff (PDF)

Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis

The Annals of pharmacotherapy, 2023-08, Vol.57 (8), p.956-965

2023

Volltextzugriff (PDF)

Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents

The Annals of pharmacotherapy, 2023-12, Vol.57 (12), p.1436-1448

2023

Volltextzugriff (PDF)

Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications

Progress in brain research, 2016-01, Vol.223, p.191-214

D'Souza, Manoranjan S

2016

Volltextzugriff (PDF)

Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits

Neuropharmacology, 2012-03, Vol.62 (3), p.1564-1573

2012

Volltextzugriff (PDF)

Targeting the renin angiotensin system for the treatment of anxiety and depression

Pharmacology, biochemistry and behavior, 2020-12, Vol.199, p.173063-173063, Article 173063

2020

Volltextzugriff (PDF)

Endogenous opioid system: a promising target for future smoking cessation medications

Psychopharmacology, 2017-05, Vol.234 (9-10), p.1371-1394

2017

Volltextzugriff (PDF)

Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation

Neuropharmacology, 2014-01, Vol.76 (0), p.554-565

2014

Volltextzugriff (PDF)

Association between nicotine withdrawal and reward responsiveness in humans and rats

JAMA psychiatry (Chicago, Ill.), 2014-11, Vol.71 (11), p.1238

2014

Volltextzugriff (PDF)

N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking

Psychopharmacology, 2013-01, Vol.225 (2), p.473-482

2013

Volltextzugriff (PDF)

Differential role of N-methyl-D-aspartate receptor-mediated glutamate transmission in the nucleus accumbens shell and core in nicotine seeking in rats

The European journal of neuroscience, 2014-04, Vol.39 (8), p.1314-1322

2014

Volltextzugriff (PDF)

Prenatal exposure to methamphetamine in rats induces endothelial dysfunction in male but not female adult offspring

Naunyn-Schmiedeberg's archives of pharmacology, 2021-05, Vol.394 (5), p.981-988

2021

Volltextzugriff (PDF)

Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart

PloS one, 2017-06, Vol.12 (6), p.e0179129-e0179129

2017

Volltextzugriff (PDF)

Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine

Behavioural brain research, 2018-02, Vol.338, p.56-65

2018

Volltextzugriff (PDF)

Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia

Journal of Pharmacy Technology, 2023-04, Vol.39 (2), p.88-94

2023

Volltextzugriff (PDF)

Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats

Psychopharmacology, 2017-05, Vol.234 (9-10), p.1603-1614

2017

Volltextzugriff (PDF)

Regulator of G protein signaling 2 differentially regulates nicotine‐induced anxiolytic‐ and antidepressant‐like effects in mice

The European journal of neuroscience, 2018-09, Vol.48 (5), p.2110-2117

2018

Volltextzugriff (PDF)

Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats

Neuropharmacology, 2011-12, Vol.61 (8), p.1399-1405

2011

Volltextzugriff (PDF)

The "stop" and "go" of nicotine dependence: role of GABA and glutamate

Cold Spring Harbor perspectives in medicine, 2013-06, Vol.3 (6), p.a012146-a012146

2013

Volltextzugriff (PDF)

Regulator of G-Protein Signaling 5 Protein Deficiency Differentially Influences Blood Pressure, Vascular and Behavioral Effects in Aged Male Mice

Journal of cardiovascular pharmacology, 2022-08, Vol.80 (2), p.305-313

2022

Volltextzugriff (PDF)

Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments

Addiction science & clinical practice, 2011-07, Vol.6 (1), p.4-16

2011

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Glutamatergic transmission in drug reward: implications for drug addiction

Differential methamphetamine-induced behavioral effects in male and female mice lacking regulator of G Protein signaling 4

Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits

Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype‑2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence

Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence

Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis

Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents

Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications

Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits

Targeting the renin angiotensin system for the treatment of anxiety and depression

Endogenous opioid system: a promising target for future smoking cessation medications

Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation

Association between nicotine withdrawal and reward responsiveness in humans and rats

N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking

Differential role of N-methyl-D-aspartate receptor-mediated glutamate transmission in the nucleus accumbens shell and core in nicotine seeking in rats

Prenatal exposure to methamphetamine in rats induces endothelial dysfunction in male but not female adult offspring

Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart

Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine

Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia

Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats

Regulator of G protein signaling 2 differentially regulates nicotine‐induced anxiolytic‐ and antidepressant‐like effects in mice

Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats

The "stop" and "go" of nicotine dependence: role of GABA and glutamate

Regulator of G-Protein Signaling 5 Protein Deficiency Differentially Influences Blood Pressure, Vascular and Behavioral Effects in Aged Male Mice

Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments

Suchergebnisse filtern